Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences.Section 32, a venture capital fund that invests in frontiers of technology…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
